Clinuvel PharmaceuticalsCUV 
$10.13-1.19%24h
-1.19%24h
Global rank11332
Market cap$500.75M
Change 7d-
YTD Performance-6.43%
SP500 benchmarkUnderperform
P/E17.15
P/S9.45
Revenue$52.99M
Earnings$20.71M
Dividend yield-
Main Sector
Healthcare
Category
Clinuvel Pharmaceuticals (CUV) Net Assets
CUV Net Assets in 2023: $164.63M
As of 28 Oct 2024, Clinuvel Pharmaceuticals net assets is $164.63M, an increase of 31.12% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Clinuvel Pharmaceuticals overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Clinuvel Pharmaceuticals Net Assets History from 2019 to 2024
-
Value:-
CUV Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $164.63M | 31.12% |
| 2022 | $125.56M | 27.16% |
| 2021 | $98.74M | 34.03% |
| 2020 | $73.67M | 28.84% |
| 2019 | $57.18M | - |
View the Top Net Assets Companies
